Form 4: Neumora Therapeutics President Joshua Pinto Sells Shares to Cover Tax Obligations

Joshua Pinto, President of Neumora Therapeutics, sold 8,048 shares of common stock on February 18, 2025, to satisfy withholding obligations related to vesting restricted stock units.

Summary

• On February 18, 2025, Joshua Pinto, President of Neumora Therapeutics, sold 8,048 shares of Neumora Therapeutics (NMRA) common stock.
• The sale was executed at a weighted average price of $1.6746 per share, with individual trades ranging from $1.66 to $1.6995.
• The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on April 18, 2024, and amended on May 22, 2024.
• The purpose of the sale was to cover withholding tax obligations associated with the vesting of restricted stock units.
• Following the transaction, Pinto directly owns 76,952 shares and indirectly owns 138,965 shares through Maple DE Holdings LLC.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (stock sale for tax obligations) and does not contain any information that would significantly impact investor sentiment positively or negatively.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and are generally viewed as routine transactions.

Key Dates